PCSK9 and Alzheimer disease: Although CSF levels of PCSK9—the primary protein responsible for degrading APOE-binding receptors—have been reported as elevated in patients with AD in one study [50], we observed no differences in CSF PCSK9 concentrations between AD and control groups.